Muutke küpsiste eelistusi

Neurobiology of Mental Illness 4th Revised edition [Pehme köide]

Edited by (Icahn School of Medicine at Mount Sinai), Edited by , Edited by (Departments of Psychiatry, Neuroscience and Genetic and Genomic Sciences, Icahn ), Edited by (Department of Neuroscience; and Director, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai)
  • Formaat: Paperback / softback, 1248 pages, kõrgus x laius x paksus: 278x216x48 mm, kaal: 2844 g
  • Ilmumisaeg: 19-Jun-2014
  • Kirjastus: Oxford University Press Inc
  • ISBN-10: 0199398461
  • ISBN-13: 9780199398461
Teised raamatud teemal:
  • Pehme köide
  • Hind: 145,00 €*
  • * saadame teile pakkumise kasutatud raamatule, mille hind võib erineda kodulehel olevast hinnast
  • See raamat on trükist otsas, kuid me saadame teile pakkumise kasutatud raamatule.
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Lisa soovinimekirja
  • Formaat: Paperback / softback, 1248 pages, kõrgus x laius x paksus: 278x216x48 mm, kaal: 2844 g
  • Ilmumisaeg: 19-Jun-2014
  • Kirjastus: Oxford University Press Inc
  • ISBN-10: 0199398461
  • ISBN-13: 9780199398461
Teised raamatud teemal:
Our understanding of the neurobiological basis of psychiatric disease has accelerated in the past five years. The fourth edition of Neurobiology of Mental Illness has been completely revamped given these advances and discoveries on the neurobiologic foundations of psychiatry. Like its predecessors the book begins with an overview of the basic science. The emerging technologies in Section 2 have been extensively redone to match the progress in the field including new chapters on the applications of stem cells, optogenetics, and image guided stimulation to our understanding and treatment of psychiatric disorders. Sections 3 through 8 pertain to the major psychiatric syndromes-the psychoses, mood disorders, anxiety disorders, substance use disorders, dementias, and disorders of childhood-onset. Each of these sections includes our knowledge of their etiology, pathophysiology, and treatment. The final section discusses special topic areas including the neurobiology of sleep, resilience, social attachment, aggression, personality disorders and eating disorders. In all, there are 32 new chapters in this volume including unique insights on DSM-5, the Research Domain Criteria (RDoC) from NIMH, and a perspective on the continuing challenges of diagnosis given what we know of the brain and the mechanisms pertaining to mental illness. This book provides information from numerous levels of analysis including molecular biology and genetics, cellular physiology, neuroanatomy, neuropharmacology, epidemiology, and behavior. In doing so it translates information from the basic laboratory to the clinical laboratory and finally to clinical treatment. No other book distills the basic science and underpinnings of mental disorders and explains the clinical significance to the scope and breadth of this classic text. The result is an excellent and cutting-edge resource for psychiatric residents, psychiatric researchers and doctoral students in neurochemistry and the neurosciences.

Arvustused

The fourth edition of Neurobiology of Mental Illness represents a remarkable contribution to promote the integration of psychiatry into biomedical sciences. . . [ It] will be a very useful text to be adopted for trainees in psychiatry and students interested in the field of neuroscience but also for all those interested who need to keep up to date with their knowledge in the field. * Antonio Ventriglio, ASUR; University of Foggia, Italy; International Journal of Social Psychiatry, 2015, Vol. 62 (1) *

Preface ix
Contributors xi
SECTION I INTRODUCTION TO BASIC NEUROSCIENCE
1(106)
Eric J. Nestler
1 Overview Of Brain Development
3(9)
John L. R. Rubenstein
2 Neurochemical Systems In The Central Nervous System
12(15)
Ariel Y. Deutch
Robert H. Roth
3 Principles Of Electrophysiology
27(12)
Evelyn K. Lambe
4 Principles Of Signal Transduction
39(25)
Jean-Antoine Girault
Paul Greengard
5 Synaptic And Neural Plasticity
64(12)
Said Kourrich
Antonello Bonci
6 Principles Of Molecular Biology
76(12)
Steven E. Hyman
Eric J. Nestler
7 Epigenetics Of Psychiatric Diseases
88(19)
Bryan E. McGill
Huda Y. Zoghbi
SECTION II NEW METHODS AND NEW TECHNOLOGIES FOR PRECLINICAL AND CLINICAL NEUROBIOLOGY
107(114)
Karl Deisseroth
8 Transgenic Tools And Animal Models Of Mental Illness
109(14)
Lisa M. Monteggia
William A. Carlezon Jr.
Ralph J. DiLeone
9 Application Of Stem Cells To Understanding Psychiatric Disorders
123(15)
Kimberly M. Christian
Hongjun Song
Guo-li Ming
10 Optogenetic Technologies For Psychiatric Disease Research: Current Status And Challenges
138(10)
Lief E. Fenno
Karl Deisseroth
11 Blood--Brain Barrier Opening And Drug Delivery Using Focused Ultrasound And Microbubbles
148(12)
Elisa E. Konofagou
12 Genetic Methodologies And Applications
160(12)
Shaun M. Purcell
13 The Brain And Its Epigenome
172(11)
Amanda C. Mitchell
Yan Jiang
Cyril J. Peter
Ki A. Goosens
Schahram Akbarian
14 Network Methods For Elucidating The Complexity Of Common Human Diseases
183(16)
Eric E. Schadt
15 Brain Imaging Methodologies
199(13)
Hanzhang Lu
Yihong Yang
Peiying Liu
16 Image-Guided Brain Stimulation
212(9)
Mark S. George
Joseph J. Taylor
Jaimie M. Henderson
SECTION III PSYCHOTIC DISORDERS
221(144)
Pamela Sklar
17 Diagnosis Of The Psychoses
223(9)
Lianne Morris Smith
Julie W. Messinger
Dolores Malaspina
18 Genetics Of Schizophrenia And Bipolar Disorder
232(15)
Pamela Sklar
19 Genomic Syndromes In Schizophrenia: Overlapping Phenotypes
247(9)
George Kirov
Michael C. O'Donovan
Michael J. Owen
20 Neuroimaging Of Psychotic Disorders
256(13)
Stephan Heckers
Neil Woodward
Dost Ongur
21 Cognitive And Motivational Neuroscience Of Psychotic Disorders
269(18)
Alan Anticevic
Erin C. Dowd
Deanna M. Barch
22 Mouse Models Of Schizophrenia And Bipolar Disorder
287(14)
Mikhail V. Pletnikov
Christopher A. Ross
23 Cortical Gaba Neurons In Schizophrenia
301(10)
Allison A. Curley
David A. Lewis
24 Synaptic Disease In Psychiatry
311(16)
Seth G. N. Grant
25 Neurodevelopment And Schizophrenia
327(11)
Ester J. Kwon
Takahiro Soda
Li-Huei Tsai
26 Neurobiology Of Mental Illness Psychosis Proneness
338(8)
Raquel E. Gur
27 Psychotic Disorders: Neurochemistry And Pharmacotherapy
346(9)
Carol A. Tamminga
Elena I. Ivleva
28 The Neurobiology Of Bipolar Disorder
355(10)
Katherine E. Burdick
Stephen J. Haggarty
Roy Perlis
SECTION IV MOOD DISORDERS
365(162)
Helen S. Mayberg
29 The Diagnosis Of Mood Disorders
367(29)
Jan Fawcett
Brant Hager
30 Genetics Of Depression
396(15)
Douglas F. Levinson
31 Animal Models Of Mood Disorders
411(14)
Georgia E. Hodes
Scott J. Russo
32 Molecular And Cellular Pathogenesis Of Depression And Mechanisms For Treatment Response
425(13)
Ronald S. Duman
33 Pathogenesis Of Depression: Clinical Studies
438(17)
Maura A. Furey
Daniel C. Mathews
Carlos A. Zarate Jr.
34 Neural Circuitry Of Depression
455(15)
Joseph L. Price
Wayne C. Drevets
35 Neurobiology Of Depression In Later Life: Anatomy Of Melancholia
470(13)
K. Ranga Rama Krishnan
36 Gonadal Steroids And Mood Disorders
483(13)
David R. Rubinow
Peter J. Schmidt
Claire D. Craft
37 Depression And Medical Illness
496(12)
Tami D. Benton
Joshua Blume
Paul Crits-Christoph
Benoit Dube
Dwight L. Evans
38 Treatments For Depression
508(19)
Dan V. Iosifescu
James W. Murrough
Dennis S. Charney
SECTION V ANXIETY DISORDERS
527(146)
Kerry J. Ressler
39 Diagnosis Of Anxiety Disorders
529(8)
Meghan E. Keough
Murray B. Stein
Peter P. Roy-Byrne
40 Genetics Of Anxiety Disorders
537(12)
Javier A. Perez
Takeshi Otowa
Roxann Roberson-Nay
John M. Hettema
41 Neurobiology Of Fear And Anxiety: Contributions Of Animal Models To Current Understanding
549(18)
Christopher K. Cain
Gregory M. Sullivan
Joseph E. LeDoux
42 Differential Roles Of Gaba Receptors In Anxiety
567(13)
Hanns Mohler
43 Prefrontal Cortex Regulation Of Emotion And Anxiety
580(13)
Bronwyn M. Graham
Mohammed R. Milad
44 Developmental Components Of Fear And Anxiety In Animal Models
593(13)
Siobhan S. Pattwell
Anne-Marie Mouly
Regina M. Sullivan
Francis S. Lee
45 Functional Neurocircuitry And Neuroimaging Studies Of Anxiety Disorders
606(15)
Madeleine S. Goodkind
Anett Gyurak
Amit Etkin
46 Novel Treatment Approaches For Anxiety Disorders
621(15)
Anita Van Zwieten
Gail A. Alvares
Adam J. Guastella
47 Pharmacotherapy Of Anxiety Disorders
636(10)
James W. Murrough
Dan V. Iosifescu
Dennis S. Charney
48 Neurobiology And Treatment Of OCD
646(16)
Susanne E. Ahmari
H. Blair Simpson
49 Neurobiology And Treatment Of PTSD
662(11)
Karen E. Murray
Orion P. Keifer Jr.
Kerry J. Ressler
Seth Davin Norrholm
Tanja Jovanovic
SECTION VI SUBSTANCE USE DISORDERS
673(116)
Antonello Bonci
Nora D. Volkow
50 Animal Models Of Addiction
675(8)
Rafael Maldonado
J. David Jentsch
Brigitte L. Kieffer
Christopher J. Evans
51 Cellular And Molecular Mechanisms Of Addiction
683(13)
Kathryn J. Reissner
Peter W. Kalivas
52 The Genetic Basis Of Addictive Disorders
696(10)
David Goldman
53 Brain Development And The Risk For Substance Abuse
706(10)
Kristina Caudle
B.J. Casey
54 Molecular Imaging In Addictive Disorders
716(16)
Chelsea L. Robertson
Steven M. Berman
Edythe D. London
55 Brain, Reward, And Drug Addiction
732(10)
Vani Pariyadath
Martin P. Paulus
Elliot A. Stein
56 Magnetic Resonance Spectroscopy Studies In Substance Abusers
742(19)
Linda Chang
Christine C. Cloak
John L. Holt
57 Pharmacotherapy Of Substance Use Disorders
761(11)
Jane B. Acri
Phil Skolnick
58 Epidemiology Of Substance Use Disorders
772(17)
Denise B. Kandel
Mei-Chen Hu
Pamela C. Griesler
SECTION VII DEMENTIA
789(142)
David M. Holtzman
59 Clinical And Neuropsychological Features Of Alzheimer's Disease
791(14)
Jason Hassenstab
Jeffrey Burns
John C. Morris
60 The Genetics Of Alzheimer's Disease
805(5)
Rudolph E. Tanzi
61 Experimental Animal Models Of Alzheimer's Disease
810(11)
Dave Morgan
62 Structural, Functional, And Molecular Neuroimaging Biomarkers For Alzheimer's Disease
821(13)
James B. Brewer
Jorge Sepulcre
Keith A. Johnson
63 Fluid Biomarkers For Alzheimer's Disease
834(10)
Anne M. Fagan
64 Current Therapies For Alzheimer's Disease
844(10)
Mary Sano
Judith Neugroschl
65 Disease-Modifying Therapies For Alzheimer's Disease
854(18)
Joshua D. Grill
Jeffrey Cummings
66 Lewy Body Dementias
872(15)
Stella Karantzoulis
James E. Galvin
67 Clinical Features And Pathogenesis Of Frontotemporal Dementia
887(13)
Georges Naasan
Bruce Miller
68 Pathogenesis, Diagnosis, And Treatment Of Vascular And Mixed Dementias
900(31)
Helena Chang Chui
69 Clinical Features And Pathogenesis Of Prion Disease
Joel C. Watts
Michael D. Geschwind
SECTION VIII PSYCHIATRIC DISORDERS OF CHILDHOOD ONSET
931(134)
Joseph D. Buxbaum
70 Epidemiology Of Neuropsychiatry And Developmental Disorders Of Childhood
933(11)
Elise B. Robinson
Benjamin M. Neale
Mark J. Daly
71 Rare Variants Of Substantial Effect In Psychiatric Disorders Of Childhood Onset
944(11)
Heather C. Mefford
72 Epigenetics In Early Life Programming
955(12)
Tracy L. Bale
73 Animal Models In Psychiatric Disorders Of Childhood Onset
967(13)
Richard Paylor
Alexia M. Thomas
Surabi Veeraragavan
Shannon M. Hamilton
74 Neuropathology And Synaptic Alterations In Neurodevelopmental Disorders
980(15)
Mara Dierssen
Salvador Martinez
75 Functional Connectivity: Application To Developmental Disorders
995(15)
Luke Bloy
Ragini Verma
Timothy P. L. Roberts
76 Intellectual Disability Syndromes
1010(12)
Charles E. Schwartz
Fiorella Gurrieri
Giovanni Neri
77 Autism Spectrum Disorders
1022(12)
Alexander Kolevzon
A. Ting Wang
David Grodberg
Joseph D. Buxbaum
78 Neurobiology Of Attention Deficit/Hyperactivity Disorder
1034(14)
Stephen V. Faraone
Joseph Biederman
79 Tourette Syndrome And TIC Disorders
1048(13)
Kyle Williams
Michael H. Bloch
Matthew W. State
Christopher Pittenger
80 Novel Therapeutics In Childhood Onset Psychiatric Disorders
1061(4)
Dorothy E. Grice
Alexander Kolevzon
Walter E. Kaufmann
Joseph D. Buxbaum
SECTION IX SPECIAL TOPIC AREAS
1065(122)
Dennis S. Charney
81 DSM-5 Overview And Goals
1067(5)
David J. Kupfer
Susan K. Schultz
82 The Infirmities Of Psychiatric Diagnosis
1072(4)
Steven E. Hyman
83 Toward Precision Medicine In Psychiatry: The Nimh Research Domain Criteria Project
1076(13)
Bruce N. Cuthbert
Thomas R. Insel
84 The Neurobiology Of Personality Disorders: The Shift To DSM-5
1089(14)
M. Mercedes Perez-Rodriguez
Antonia S. New
Larry J. Siever
85 The Neurobiology Of Aggression
1103(9)
R. James R. Blair
86 The Neurobiology Of Social Attachment
1112(15)
Adam S. Smith
Kelly Lei
Zuoxin Wang
87 The Neurobiology Of Sleep
1127(17)
Giulio Tononi
Chiara Cirelli
88 The Neurobiology Of Resilience
1144(27)
Adriana Feder
Margaret Haglund
Gang Wu
Steven M. Southwick
Dennis S. Charney
89 The Neurobiology Of Eating Disorders
1171(16)
Thomas B. Hildebrandt
Amanda Downey
Index 1187
Dennis S. Charney, MD is Dean at the Icahn School of Medicine at Mount Sinai, Executive Vice President for Academic Affairs, The Mount Sinai Medical Center, and Anne and Joel Ehrenkranz Professor in the Departments of Psychiatry, Neuroscience, and Pharmacology & Systems Therapeutics at the Icahn School of Medicine at Mount Sinai in New York, NY. He is a world expert in the neurobiology and treatment of mood and anxiety disorders. He has made fundamental contributions to the understanding of neural circuits and neurochemistry related to human anxiety, fear, mood and discovery of new treatment for mood and anxiety disorders. He later expanded this area into pioneering research related to the psychobiological mechanisms of human resilience to stress. His work has been carried out over two decades at Yale University School of Medicine, and during four years at the National Institute of Mental Health (NIMH). It continues today at the Icahn School of Medicine at Mount Sinai.